secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2022-04-05T23:59:59+00:00
Accession:  0000950142-22-001297
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Noel Spiegel will not stand for re-election at vTv Therapeutics 2022 annual meeting
--------------------------------------------------------------------------------

- Noel Spiegel, Audit Committee Chair, notified Company he will not stand for re-election at 2022 annual meeting.
- Decision not due to disagreement with Company's operations, policies, or practices.
- Spiegel served as director and Audit Committee Chair since IPO in 2015.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000095014222001297/0000950142-22-001297-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000095014222001297/eh220241644_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950142-22-001297

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer